# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Annie Oakley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI021-SYN-TD
- Date: 1925-04-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ruth Ellingsen, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Eight-week pernicious anemia review, endoscopy results, and back pain review. **S**

## History of present illness

Mrs. Oakley returns eight weeks after starting B12 replacement. She completed the four weekly injections four weeks ago, and her first monthly injection is given today. Her energy is back to normal, she climbs stairs without breathlessness, and her tongue has healed. The tingling in her feet is much less and she no longer feels unsteady in the dark. Her endoscopy three and a half weeks ago showed corpus-predominant atrophic gastritis with intestinal metaplasia and ECL-cell hyperplasia, no neuroendocrine tumor, dysplasia, or cancer, and no H. pylori; two small hyperplastic polyps were removed. She finished eight sessions of physical therapy last week and does her home program daily. Her back pain is better but flares after long days at the range. **S**

| Element | Detail |
|---|---|
| Interval change | Energy normal; tongue healed; tingling much less |
| Adherence | Four of four weekly injections given |
| Endoscopy | Autoimmune atrophic gastritis; no neuroendocrine tumor or neoplasia |
| Back pain | Better after eight therapy sessions; flares after long days at the range |
| Falls | None |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy normal; weight up 1.1 kg since the first visit |
| Respiratory | Negative | No breathlessness on stairs |
| Gastrointestinal | Negative | No indigestion, black stools, or bleeding after the endoscopy |
| Neurological | Positive | Occasional mild tingling of the toes; balance normal in the dark |
| Musculoskeletal | Positive | Low back pain after long standing |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |

6 systems reviewed. **S**

## Current medications

- Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once a month, lifelong **S**
- Ferrous sulfate 325 mg oral tablet (65 mg elemental iron), one tablet by mouth every other day with orange juice **S**
- Naproxen sodium 220 mg oral tablet, one tablet by mouth with food up to twice daily as needed for back pain flares **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/70 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 47.3 kg; BMI 20.5 kg/m². All vital signs are synthetic.

Hemoglobin: 12.3 g/dL; MCV: 96 fL; White cell count: 5.4 10*3/uL; Platelets: 245 10*3/uL; Methylmalonic acid: 0.28 umol/L; Ferritin: 14 ng/mL (low); Transferrin saturation: 11% (low); PHQ-2: 0; Back pain, 0 to 10: 4; Oswestry Disability Index (percent): 22. All results are synthetic.

## Change since baseline

- Hemoglobin: 8.9 g/dL (low) at baseline, 12.3 g/dL at this visit **S**
- MCV: 114 fL (high) at baseline, 96 fL at this visit **S**
- White cell count: 3.6 10*3/uL (low) at baseline, 5.4 10*3/uL at this visit **S**
- Platelets: 128 10*3/uL (low) at baseline, 245 10*3/uL at this visit **S**
- Methylmalonic acid: 2.1 umol/L (high) at baseline, 0.28 umol/L at this visit **S**
- Ferritin: 52 ng/mL at baseline, 14 ng/mL (low) at this visit **S**
- Transferrin saturation: 34% at baseline, 11% (low) at this visit **S**
- PHQ-2: 1 at baseline, 0 at this visit **S**
- Back pain, 0 to 10: 5 at baseline, 4 at this visit **S**
- Oswestry Disability Index (percent): 28 at baseline, 22 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well, good color |
| Mouth | Tongue normal |
| Neurological | Vibration reduced at the toes and normal at the ankles; proprioception normal; ankle reflexes present; Romberg negative |
| Back | Mild paraspinal tenderness; full strength; straight-leg raise negative; no saddle numbness |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Pernicious anemia, hematologic remission, neuropathy improving** (D51.0). Hemoglobin 12.3 g/dL, MCV 96 fL, white cells 5.4, and platelets 245 are normal at eight weeks, and MMA has fallen from 2.10 to 0.28 micromol/L. **S**
   - Monthly cyanocobalamin 1000 micrograms intramuscularly for life, the first given today.
   - Neurologic examination at each visit.
2. **Autoimmune atrophic gastritis** (K29.40). Corpus-predominant atrophy with intestinal metaplasia, an advanced form, with no neuroendocrine tumor or neoplasia and no H. pylori. **S**
   - Surveillance endoscopy in about three years, chosen with her after discussing her gastric cancer and neuroendocrine tumor risk.
   - Report indigestion, difficulty swallowing, black stools, or weight loss promptly.
3. **Iron deficiency without anemia** (E61.1). Ferritin has fallen from 52 to 14 ng/mL and transferrin saturation to 11 percent as new red cells used her stores; reduced gastric acid lowers iron absorption. Iron deficiency in a postmenopausal woman needs the colon examined as well. **S**
   - Ferrous sulfate 325 mg every other day with orange juice.
   - Colonoscopy to complete the GI evaluation; the endoscopy already included duodenal biopsies, which were normal.
   - Blood count in about four weeks, then iron studies at the next review.
4. **Chronic low back pain, improving** (M54.50). Pain 4 of 10, down from 5, and Oswestry score 22 percent, down from 28. No red flags. Platelets are now normal and eGFR was 93. **S**
   - Continue the home exercise program; add a tai chi class.
   - Naproxen 220 mg with food up to twice a day as needed for flares, not daily.
   - No imaging.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Blood count with MCV | Eight weeks after starting B12 replacement | Completed today | Hemoglobin 12.3 g/dL, MCV 96 fL, white cells 5.4, platelets 245: normal |
| Laboratory | MMA | One week to three months after starting replacement | Completed today | 0.28 micromol/L, normal, down from 2.10 |
| Laboratory | Iron studies | When red cell production recovers | Completed today | Ferritin 14 ng/mL, transferrin saturation 11 percent: iron deficiency |
| Laboratory | Serum B12 | Not routinely retested once replacement has begun | Not indicated | Not repeated |
| Examination | Neurologic examination (vibration, proprioception, gait, cognition) | At diagnosis and at follow-up visits for B12 deficiency with neurologic findings | Completed today | Improved: vibration reduced at the toes only; Romberg negative |
| Imaging | Upper endoscopy with topographic gastric biopsies | At diagnosis of pernicious anemia; surveillance by individual risk | Up to date | Done three and a half weeks ago; no neuroendocrine tumor or neoplasia; surveillance in about three years |
| Laboratory | H. pylori testing | Once in atrophic gastritis | Up to date | Negative on gastric biopsies |
| Imaging | Colonoscopy for iron deficiency | At diagnosis of iron deficiency in a postmenopausal woman | Ordered | To be booked within four weeks |
| Laboratory | Blood count after starting oral iron | About one month after starting oral iron | Due | In about four weeks |
| Survey | Back pain intensity and Oswestry Disability Index | Every visit while treating chronic low back pain | Completed today | Pain 4 of 10; Oswestry 22 percent |
| Survey | Depression screen (PHQ-2) | Periodically | Completed today | Score 0 |
| Self-management | Exercise therapy for back pain | Eight weeks, then a home program | Completed today | Eight sessions completed; home program daily; tai chi added |
| Medication safety | NSAID safety | When starting and at each visit | Completed today | Platelets 245 and eGFR 93; as-needed use with food only |
| Imaging | Lumbar spine imaging | Only with red flags or before an intervention | Not indicated | No red flags |
| Examination | Fall risk | Every visit while neuropathy persists | Completed today | Romberg negative; no falls |

## Goal progress

- Normal hemoglobin and MCV within eight weeks of starting B12 replacement. Outcome by 1925-04-06: Hemoglobin 12.3 g/dL and MCV 96 fL at eight weeks. **S**
- Stop the progression of neuropathy and recover balance, with no falls. In progress; target 1925-07-06. **S**
- Reduce back pain to 3 of 10 or less and the Oswestry score below 20 percent by the five-month review. In progress; target 1925-07-06. **S**
- Return to teaching full shooting classes. In progress; target 1925-07-06. **S**

## Medication changes

- Started: Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once a month, lifelong **S**
- Started: Ferrous sulfate 325 mg oral tablet (65 mg elemental iron), one tablet by mouth every other day with orange juice **S**
- Started: Naproxen sodium 220 mg oral tablet, one tablet by mouth with food up to twice daily as needed for back pain flares **S**

## Guideline basis

- Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014), British Society for Haematology
- AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021), American Gastroenterological Association
- AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia (2020), American Gastroenterological Association
- Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017), American College of Physicians
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge

## Follow-up

- Monthly B12 injections with the practice nurse. Colonoscopy within four weeks. Blood count in about four weeks. Review in three months with blood count, iron studies, and back pain scores. **S**
- Next scheduled visit 1925-07-06: five-month pernicious anemia, iron, neuropathy, and back pain review. **S**
